Added to YB: 2026-01-14
Pitch date: 2025-11-10
LFCR [bullish]
Lifecore Biomedical, Inc.
+2.75%
current return
Author Info
No bio for this author
Company Info
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States.
Market Cap
$283.2M
Pitch Price
$7.26
Price Target
32.00 (+322%)
Dividend
N/A
EV/EBITDA
-124.05
P/E
-5.93
EV/Sales
3.51
Sector
Life Sciences Tools and Services
Category
turnaround
Lifecore Biomedical, Inc. - $LFCR
LFCR: Sterile injectable CDMO turnaround undervalued as strong operational progress hasn't hit financials yet. Fixed costs + 9 new customer wins + $40M liquidity. Q4 guidance: $34-36M rev, 23% EBITDA margin at 20% capacity. Mid-term: $178-205M rev, 25%+ margins = $16-32 price target.
Read full article (6 min)